Compare DTM & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTM | DVA |
|---|---|---|
| Founded | 2021 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Misc Health and Biotechnology Services |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 14.9B |
| IPO Year | 2021 | 2003 |
| Metric | DTM | DVA |
|---|---|---|
| Price | $126.06 | $183.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | $142.82 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 878.9K | 570.2K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ 19.44 | N/A |
| EPS | 2.36 | ★ 6.86 |
| Revenue | $1,243,000,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $7.56 | $3.85 |
| Revenue Next Year | $5.98 | $3.07 |
| P/E Ratio | $52.95 | ★ $26.78 |
| Revenue Growth | ★ 26.71 | 6.46 |
| 52 Week Low | $104.99 | $101.00 |
| 52 Week High | $152.88 | $247.49 |
| Indicator | DTM | DVA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates maximum revenue from pipeline segment that includes interstate pipelines, storage systems, gathering lateral pipelines and compression and surface facilities.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.